Related references
Note: Only part of the references are listed.Impaired signaling through the Fms-like tyrosine kinase 3 receptor increases osteoclast formation and bone damage in arthritis
Mattias N. D. Svensson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Higher circulating levels of chemokine CXCL10 in patients with breast cancer: Evaluation of the influences of tumor stage and chemokine gene polymorphism
A. Jafarzadeh et al.
CANCER BIOMARKERS (2016)
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
Claudia Cantoni et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma
M. Sadeghi et al.
BRITISH JOURNAL OF CANCER (2015)
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
Michael S. Isakoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma
Francoise Redini et al.
FRONTIERS IN ONCOLOGY (2015)
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment
J. S. Whelan et al.
ANNALS OF ONCOLOGY (2015)
Identification of a Plasma Four-microRNA Panel as Potential Noninvasive Biomarker for Osteosarcoma
Feng Lian et al.
PLOS ONE (2015)
Spinal IFN-γ-induced protein-10 (CXCL10) mediates metastatic breast cancer-induced bone pain by activation of microglia in rat models
Huilian Bu et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis
Jian Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Impact of RANK signalling on survival and chemotherapy response in osteosarcoma
Zsuzsanna Bago-Horvath et al.
PATHOLOGY (2014)
Infiltrating Macrophages Promote Prostate Tumorigenesis via Modulating Androgen Receptor-Mediated CCL4-STAT3 Signaling
Lei-Ya Fang et al.
CANCER RESEARCH (2013)
Lessons Learned From Lung Cancer Genomics: The Emerging Concept of Individualized Diagnostics and Treatment
Reinhard Buettner et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The prognostic significance of chemokine receptor CXCR3 expression in colorectal carcinoma
Zhenqian Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
A systems biology approach reveals common metastatic pathways in osteosarcoma
Ricardo J. Flores et al.
BMC SYSTEMS BIOLOGY (2012)
STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma
Bing Tu et al.
CANCER LETTERS (2012)
Building strong bones: molecular regulation of the osteoblast lineage
Fanxin Long
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo
Terry O'Reilly et al.
ANTI-CANCER DRUGS (2011)
Elevated Expression of CXC Chemokines in Pediatric Osteosarcoma Patients
Yiting Li et al.
CANCER (2011)
EGFR-targeted therapies combined with chemotherapy for treating advanced non-small-cell lung cancer: a meta-analysis
Peng Chen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency
Venetia Bigley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma
Jan Smida et al.
CLINICAL CANCER RESEARCH (2010)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs
Emmanuelle Pradelli et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Feedback control of regulatory T cell homeostasis by dendritic cells in vivo
Guillaume Darrasse-Jeze et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
A complex pattern of chemokine receptor expression is seen in osteosarcoma
Irene von Luettichau et al.
BMC CANCER (2008)
Killer Dendritic Cells Link Innate and Adaptive Immunity against Established Osteosarcoma in Rats
Camille Chauvin et al.
CANCER RESEARCH (2008)
Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands
Marco Wendel et al.
CANCER RESEARCH (2008)
Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells
Jo Vandercappellen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes
K. Kawada et al.
ONCOGENE (2007)
Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines
Carole Speziani et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Steady-state and inflammatory dendritic-cell development
Ken Shortman et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer
Tonya C. Walser et al.
CANCER RESEARCH (2006)
Results of the Brazilian Osteosarcoma Treatment Group studies III and IV:: Prognostic factors and impact on survival
AS Petrilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Biomarkers in cancer screening, research and detection: present and future: a review
S. Kumar et al.
BIOMARKERS (2006)
Expression profiles of osteosarcoma that can predict response to chemotherapy
TK Man et al.
CANCER RESEARCH (2005)
Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: Determinations of a panel of nine cytokines in clinical sample culture supernatants
NC duPont et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2005)
Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
SS Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function
JM Lean et al.
BLOOD (2001)
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Y Yamamoto et al.
BLOOD (2001)
Share Paper
